Dr. Naresh Kharbuja, MD

Description

Professional Experience

• Consultant Neurologist: Clinic One: 2022 – till date

• Fellowship in Neuromedicine: Grande International Hospital: 2022 – till date

Education and Training

• MD (Internal Medicine) – Southeast University, Nanjing, Jiangsu Province, P. R. China, 2021

• MBBS – West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, P. R. China, 2016

Publications

• Kharbuja, N.,Wu M,Han YC, Liu D,Wang B,Liu BC. et al., Efficacy of low or high-dose rituximab treatment in membranous nephropathy: a systematic review and meta-analysis. 2021.

• Li, Z.-L., et al.ji Jl, Wen Y, Cao JY, Kharbuja N, Ni WJ, Yin D,Feng ST ,LIu,Lv LL, Liu BC. HIF-1α is transcriptionally regulated by NF-κB in acute kidney injury. American Journal of Physiology-Renal Physiology, 2021. 321(2): p. F225-F235.

• Rajan, V.et al.Shan MG, Sabina S, Naresh K,Jasmine S, Farhan K, LONG NON-CODING RNAs AND CORONARY ARTERY DISEASE.

• Sharad, P. et al,Huang Z,Yang X,Cao W,Pratiksha G,Naresh K., The Comparison of Diagnostic Significance of Narrow Band Imaging in Contrast of White Light Endoscopy in the Assessment of Nasopharyngeal Cancer. Journal of Cancer Therapy, 2020. 11(3): p. 160-171.

Training

• Residency: Department of Nephrology, Cardiology, Gastrointestinal, Respiratory, Rheumatology, Endocrine, Neurology, Emergency Medicine and Trauma, and Intensive Care Unit, at the Zhongda Hospital, Southeast University, China [2018-2021]